Molecular pharmacological approach to the disturbances of brain neuron circuits involved in schizophrenia
精神分裂症脑神经元回路紊乱的分子药理学方法
基本信息
- 批准号:06670993
- 负责人:
- 金额:$ 1.41万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1994
- 资助国家:日本
- 起止时间:1994 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
A psychotomimetic drug methamphetamine (MAP) produces a neuroleptic-responsive schizophreniform psychosis in humans while phencyclidine (PCP) psychosis includes neuroleptic-resistant symptoms which are indistinguishable from those of schizophrenis. Acute administration of MAP (4.8 mg/kg, subcutaneously (s.c.)) caused a widespread induction of nuclear c-Fos-like immunoreactivity in rat brain at 56-80 postnatal days in a dopamine antagonist-sensitive manner. The greatest density of c-Fos positive cells was found in the pyriform cortex and olfactory tubercle followed by the entorhinal cortex, II-VI layrs of the neocortex, striatum, amygdala, nucleus accumbens, septal unclei, granular cell layr of the cerebellum, thalamus, hypothalamus, substantia nigra, etc. In 8-day-old neonatal rats, acute injection of these drugs failed to cause c-fos expression from the laver II htrough V of the neocortex, but induced the proto-oncogene product in a deeper aprt of the layr VI of the neocortex, the pal … More eocortex (including the pyriform and entorhinal cortex) and the above subcortical areas. MAP-induced c-Fos positive cells in the neocortex increased in number and distribution with postnatal development and showed the adult pattern after 21-23 postnatal days. The distribution patterns of c-Fos-positive cells after PCP treatment were different from those after MAP.Thus, a single injection of PCP (5-10mg/kg, s.c.) produced the dense expression of c-Fos-like immunoreactivity in the deeper layrs (IV-VI) of the neocortex and pyriform cortex, but the very sparse expression in the striatum, olfactory tubercle and superficial layrs (I-III) of the necortex in the young adult periods in a dopamine antagonist-resistant fashion. These expression patterns were similar to those of a selective NMDA receptor antagonist dizocilpine. In the neonatal periods, PCP induced very low levels of c-Fos-like immunoreactivity in the neocortex while the pyriform cortex was dense with c-Fos positive cells. PCP-induced c-Fos-immunostaining in th brain showed the adult pattern after 21-25 postnatal days. The above developmental changes in the patterns of c-fos expression in the neocortical areas might reflect differences in responsive neuronal circuits to the drugs between the neonatal and young adult periods. Because acute or long-term behavioral effects of these drugs alter around the third week of postnatal life, these results suggest that the maturation of certain neuronal circuits in the neocortex might be crucial for the acquisition of the adult patterns of behavioral responses or motor functions. We have nowtried to identify molecules contributing to such developmental changes in the discrete brain regions because these molecules should play a pivotal role in expression and regulation of psychomotor functions that may be disturbed in schizopherenic patients. To this end, we have employed a RNA arbitarily primed PCR technique for the detection of cDNAs that represent developmentally regulate Less
一种精神病药物甲基苯丙胺(MAP)在人类中产生神经诱导的精神分裂症精神病,而苯基二肽(PCP)精神病包括与精神分裂症的神经耐受性耐药性症状。急性施用MAP(4.8 mg/kg,皮下(S.C.))在56-80天气中以多巴胺拮抗剂敏感的方式在56-80天在大鼠脑中诱导了大鼠脑的核C-FOS样免疫反应性。 The greatest density of c-Fos positive cells was found in the pyriform cortex and olfactory tubercle followed by the entorhinal cortex, II-VI layrs of the neocortex, striatum, amygdala, nuclear accumbens, septal unclei, granular cell layr of the cerebellum, thalamus, hypothalamus, substantia nigra, etc. In 8-day-old neonatal这些药物的急性注入大鼠未能引起新皮层的Laver II Hroth V的C表达,但在新皮层的Layr VI的更深层次中诱导了原始癌基因,PAL,PAL…MOLE EOCORTEX(包括吡张和内旋和内旋Corortex)和上述下属的区域。新皮层中MAP诱导的C-FOS阳性细胞随产后发育的数量和分布增加,并在产后21-23天后显示了成年模式。 PCP处理后C-FOS阳性细胞的分布模式与地图后的分布不同。 (I-III)在年轻人时期,以多巴胺拮抗剂的方式。这些表达模式与选择性NMDA受体拮抗剂dizocilpine的表达模式相似。在新生儿期间,PCP在新皮层中诱导了非常低的C-FOS样免疫反应性,而吡形皮层则伴有C-FOS阳性细胞致密。 PCP诱导的TH大脑中的C-FOS免疫染色显示出产后21-25天后的成人模式。上述新皮质区域中C-FOS表达模式的发育变化可能反映了新生儿和年轻人时期的药物反应性神经元回路的差异。由于这些药物的急性或长期行为作用发生了变化,因此这些结果表明,新皮层中某些神经元回路的成熟对于获取成人行为反应或运动功能的模式可能至关重要。现在,我们已经识别出导致离散大脑区域此类发育变化的分子,因为这些分子应在精神病患者中可能扭曲的精神运动功能的表达和调节中起关键作用。为此,我们采用了RNA仲裁PRCR技术来检测代表发育规范较少调节的cDNA
项目成果
期刊论文数量(98)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nishikawa T and Scatton B:"GABAergic inhibition of ascending serotonergic neurons in rat brain. In Serotonin in the Central Nervous System and Periphery(eds. A. Takada and G. Curzon)," Elsevier, Amsterdam,6 (1995)
Nishikawa T 和 Scatton B:“GABA 能抑制大鼠大脑中的上行血清素能神经元。中枢神经系统和外周的血清素(A. Takada 和 G. Curzon 编辑)”,Elsevier,阿姆斯特丹,6 (1995)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kashiwa A, Nishikawa T, Nishijima K, Umino A and Takahashi K.: "Dizocilpine(MK-801)elicits a tetrodotoxin-sensitive increase in extracellular release of dopamine in rat medial frontal cortex." Neurochem. Int.26. 85-90 (1995)
Kashiwa A、Nishikawa T、Nishijima K、Umino A 和 Takahashi K.:“地佐环平 (MK-801) 会引起大鼠内侧额叶皮层细胞外多巴胺释放对河豚毒素敏感的增加。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tanii Y,Nishikawa T,Hashimoto A and Takahashi K: "Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactiviy, stereotypy and ataxia in the rat." J.Pharmacol.EXP.Ther.269. 1040-1048 (1994)
Tanii Y、Nishikawa T、Hashimoto A 和 Takahashi K:“丙氨酸和丝氨酸对映体对苯环己哌啶诱导的大鼠多动症、刻板性和共济失调的立体选择性拮抗作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
岩間久行・西川徹: "精神分裂病II-おもに病因・病態論の立場から-(シリーズ精神科症例集2)" 佐藤光源編集,中山書店,東京, 396 (1994)
岩间久之和西川彻:《精神分裂症 II - 主要从病因学和病理生理学的角度 - (系列精神病病例集 2)》由佐藤光编辑,中山书店,东京,396 (1994)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hashimoto,A.et al.: "Extracellular concentration of endogenous free D-serine in the rat brain as revealed by in vivo microdialysis" Neurosuience. (印刷中).
Hashimoto, A. 等人:“通过体内微透析揭示的大鼠脑中内源性游离 D-丝氨酸的细胞外浓度”Neurosuience(正在出版)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NISHIKAWA Toru其他文献
NISHIKAWA Toru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NISHIKAWA Toru', 18)}}的其他基金
Studies on the development of novel pharmacotherapy for schizophrenia that regulates the glutamate receptors
调节谷氨酸受体的精神分裂症新型药物疗法的开发研究
- 批准号:
21390330 - 财政年份:2009
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Studies on the development of glutamate system-targeted novel pharmacotherapy for schizophrenia
谷氨酸系统靶向治疗精神分裂症新药开发研究
- 批准号:
19390302 - 财政年份:2007
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of molecular pathomechanisms of schizophrenia
阐明精神分裂症的分子病理机制
- 批准号:
17025016 - 财政年份:2005
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
A neurodevelopmental pharmacological approach to the molecular pathophysiology of schizophrenic symptoms
精神分裂症症状分子病理生理学的神经发育药理学方法
- 批准号:
14207040 - 财政年份:2002
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
A pharmacological approach to the molecular basis of disturbed brain information processing of schizophrenia
精神分裂症大脑信息处理紊乱的分子基础的药理学方法
- 批准号:
12470192 - 财政年份:2000
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
精神分裂病における神経情報処理障害の原因となる遺伝子異常の探索
寻找导致精神分裂症神经信息处理障碍的遗传异常
- 批准号:
10670929 - 财政年份:1998
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of schizophrenic symptoms
精神分裂症症状的分子机制
- 批准号:
08671124 - 财政年份:1996
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Metabolism and Physiological functions of endogenous D-serine
内源性D-丝氨酸的代谢和生理功能
- 批准号:
07557242 - 财政年份:1995
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Schizophrenic sympyoms-related disturbance of cerebral neurotransmission
精神分裂症症状相关的脑神经传递障碍
- 批准号:
04670718 - 财政年份:1992
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Behavioral and biochemical effects of schizophrenomimetic drugs, phencyclidine and methamphetamine, in the rat
精神分裂拟态药物苯环己哌啶和甲基苯丙胺对大鼠的行为和生化影响
- 批准号:
02670527 - 财政年份:1990
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
杏仁核PTEN参与甲基苯丙胺成瘾记忆调控的机制研究
- 批准号:82301676
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
腹侧被盖区多巴胺神经元投射偏向性对甲基苯丙胺自给药个体差异的影响及其机制
- 批准号:32300846
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
GPR37与多巴胺D2受体相互作用调控甲基苯丙胺成瘾的机制研究
- 批准号:82302127
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
大麻二酚通过环状RNAcircDennd1b/mi183-5p/KCNJ5轴干预甲基苯丙胺依赖的机制研究
- 批准号:82360336
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
甜菜碱调控Th17细胞分化参与甲基苯丙胺所致精神障碍的机制研究
- 批准号:82371899
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
mGluR5 Regulation of METH Reward and Sensorimotor Gating
mGluR5 对 METH 奖励和感觉运动门控的调节
- 批准号:
7610928 - 财政年份:2007
- 资助金额:
$ 1.41万 - 项目类别:
mGluR5 Regulation of METH Reward and Sensorimotor Gating
mGluR5 对 METH 奖励和感觉运动门控的调节
- 批准号:
7633169 - 财政年份:2007
- 资助金额:
$ 1.41万 - 项目类别:
mGluR5 Regulation of METH Reward and Sensorimotor Gating
mGluR5 对 METH 奖励和感觉运动门控的调节
- 批准号:
7276250 - 财政年份:2007
- 资助金额:
$ 1.41万 - 项目类别:
Elucidation of molecular pathomechanisms of schizophrenia
阐明精神分裂症的分子病理机制
- 批准号:
17025016 - 财政年份:2005
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
A neurodevelopmental pharmacological approach to the molecular pathophysiology of schizophrenic symptoms
精神分裂症症状分子病理生理学的神经发育药理学方法
- 批准号:
14207040 - 财政年份:2002
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (A)